Business
Cellceutix Announces Company Name Change to Innovation Pharmaceuticals Inc.
Cellceutix Announces Company Name Change to Innovation Pharmaceuticals Inc..
About this update from Innovation Pharmaceuticals Inc.
[{"type":"text","content":"\n\n BEVERLY, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), an emerging biopharmaceutical company, is pleased to announce to shareholders, and the public at large, that the company name is changing to Innovation Pharmaceuticals Inc. (IPI) and it has received a new Committee on Uniform Securities Identification Procedures (CUSIP) number of 45782D 100. \n Innovation Pharmaceuticals more accurately describes the innovative nature of our first-in-class pipeline of mid-stage drug candidates. These changes will have no impact on the marketability of the Company’s securities, or the ability to trade the common stock through brokerage firms. Stockholders of the Company are not required to exchange their stock certificates in connection with the name change. The Company’s common stock will continue to trade under stock symbol “CTIX” on OTCQB until market close on June 8, 2017. Trading on the OTCQB under the new Innovation Pharmaceuticals name and ticker symbol “IPIX” will begin at market open on June 9, 2017. The Company’s new website address will change to www.IPharmInc.com. In the interim, the Company will maintain www.cellceutix.com. The name change will be discussed at the upcoming live shareholder and investor conference call, to be held on Thursday, June 8, 2017, at 11am EDT. Senior Company management will be responding to recently posed questions submitted by email. Live call-in questions will also be addressed. Below are call-in details for the conference call: Title: Innovation Pharmaceuticals Shareholder and Investor Conference Call Presentation Type: Audio Webcast Event Date: Thursday, June 8, 2017, at 11am EDT Call-in Numbers: 866-682-6100 / 862-255-5401 Web Event Link: http://www.investorcalendar.com/event/15776 About the Company Headquartered in Beverly, Massachusetts, Cellceutix Corporation, to become Innovation Pharmaceuticals Inc. (IPI), will be publicly-traded under the company symbol “IPIX”. The Company is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. The Company believes it has a world-class portfolio of first-in-class lead drug candidates and is now advancing them toward market approval, while actively seeking strategic partnerships. The Company’s ...